Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B

Xiang Li(Yanbian University), Zigang Dong(Zhengzhou University)
Carcinogenesis
September 8, 2012
Cited by 43


Related Papers